Videos

Panelists discuss how recent clinical studies on viloxazine in children and adolescents with ADHD demonstrated early symptom improvement, dose-dependent efficacy, and tolerability, with the most benefit seen at 400 mg in those aged 11 and under.

Panelists discuss the clinical and practical advantages of pitolisant for patients with frequent cataplexy and concerns about controlled substances, highlighting its dual efficacy, favorable safety profile, and flexible dosing as key features that support a patient-centered, stigma-conscious approach to narcolepsy care.

Panelists discuss the importance of shared decision-making in narcolepsy care, emphasizing structured conversations that explore patient goals, treatment preferences, and concerns—while navigating practical barriers like insurance—so that therapy selection is personalized and collaborative, often requiring a multimodal approach for optimal outcomes.

“Keep, ancient lands, your storied pomp!” cries she With silent lips. “Give me your tired, your poor, Your huddled masses yearning to breathe free, The wretched refuse of your teeming shore.

H. Steven Moffic, MD, discusses social psychiatric connections to the Declaration of Independence with some psychiatric additions to life, liberty, and pursuit of happiness.

Sara Robinson, DNP, RN, PMHNP-BC, provides insight on considerations surrounding prescribing psychiatric medications for perinatal patients.

Panelists discuss the critical importance of early diagnosis and personalized treatment in narcolepsy, using a case study to illustrate how tailored therapy—considering patient preferences, comorbidities, and lifestyle factors—can improve engagement, safety, and long-term outcomes.

Panelists discuss the evolving treatment landscape for narcolepsy, highlighting the growing availability of personalized therapies, persistent challenges with diagnosis and access, and the importance of clinician advocacy and education to ensure timely, individualized care for patients.

Panelists discuss ADHD nonstimulant medication options with detailed clinical considerations.

Panelists discuss how comprehensive ADHD treatment approaches emphasize combination therapy and immediate implementation.

Rebecca Barbee, PA-C, shares tips on addressing the heat wave and its implications when talking with patients.

"As Saint Francis put his hand on the creased forehead of the sow, and told her in words and in touch blessings of earth on the sow..."

July 1 marks 50 years in psychiatry for H. Steven Moffic, MD! In celebration, he shares essential advice for aspiring psychiatrists, emphasizing ethical decision-making, flexibility, and the importance of passion in mental health careers.

Panelists discuss the critical role of pediatricians in attention-deficity/hyperactivity disorder (ADHD) diagnosis and treatment challenges.

Panelists discuss how attention-deficity/hyperactivity disorder (ADHD) risk factors include genetic, environmental, and socioeconomic influences.

"White roses, tiny and old, flare among thorns by the barn door..."

The intersection of sex and psychiatry: an important topic for patient well-being that is often avoided due to stigma.

H. Steven Moffic, MD, reflects on mental health challenges amid political turmoil, emphasizing the need for effective advocacy and support in the community.

Panelists discuss how an attention-deficity/hyperactivity disorder (ADHD) diagnosis impacts families through stress and challenges but can also provide relief and understanding. They address quality-of-life effects including academic performance, family functioning, driving safety, and the need for structure and routine management.

Panelists discuss how diagnostic challenges include ensuring symptoms are developmentally appropriate, distinguishing attention-deficity/hyperactivity disorder (ADHD) from other conditions such as depression and anxiety and using tools such as the NICHQ Vanderbilt Assessment Scales and Connors Comprehensive Behavior Rating Scale to assess symptoms across multiple settings.

"Maybe the question is a test to uncover applicants who crumble under pressure, or a tactic to learn how much dough the future doctor hopes to earn..."

Prevention of wars would reduce the extraordinary loss of lives and major trauma.

Panelists discuss how the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR) criteria for attention-deficity/hyperactivity disorder (ADHD) require at least 6 of 9 symptoms in either inattentive or hyperactive-impulsive domains, with inattentive presentations often unrecognized in girls and highly intelligent students in particular.

Panelists discuss how attention-deficity/hyperactivity disorder (ADHD) presents in a 10-year-old boy with combined presentation symptoms, emphasizing the importance of seeing difficulties across multiple settings and noting the genetic component when family history is present.

"It all depends on the child’s arrival..."

Explore best practices in child mental health through real case studies in the DSM-5-TR Casebook and Treatment Guide for Child Mental Health, featuring expert insights and treatment strategies.

Learn more from 30 case examples in the new book, DSM-5-TR Casebook and Treatment Guide for Child Mental Health.

H. Steven Moffic, MD, ponders the interesting story behind the Goldwater Rule, and whether it remains useful as is.

The DSM-5-TR Casebook and Treatment Guide for Child Mental Health provides a wide array of cases to instruct clinicians on the best practices for treating child and adolescent mental health problems.

The RECOVER open label trial demonstrated positive results for brilaroxazine for schizophrenia.